Patient P-03118

Synthetic patientONX-7 · Day 149 · 45–54 · M · baseline S20Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

13%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 ONX-7 started — Baseline state S20

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity-9
Nutritional resilience+8
GI instability-4
Toxicity-3
Treatment adherence+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level

Daily log

7/10

worsening · -0.5 vs previous 14 d

Stress level

Daily log

3.9/10

worsening · +0.5 vs previous 14 d

Pessimism score

Daily log

2.7/10

worsening · +0.3 vs previous 14 d

Sleep quality

Wearable

57.2/100

worsening · -2.6 vs previous 14 d

Libido

Daily log

5/10

worsening · -0.5 vs previous 14 d

HRV

Wearable

38.1 ms

worsening · -3.0 vs previous 14 d

Toxicity

Blood

11.7/100

worsening · +5.6 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 92 from the failing basin, 10 from restoration.

Good elements to keep

Protein (supports)
perturbation · steering +12.1
Butyrate producers intact
hidden · steering +7.5
Caffeine (supports)
perturbation · steering +4.4
Daily walks resumed
perturbation · steering +3.3
Protein
supporter · GI -6.2 next day
Caffeine
supporter · GI -3.2 next day

Main detractors to watch

Rapid metabolizer
hidden · steering -8
Low-HRV stretch
perturbation · steering -2.7
Dietary drift
perturbation · steering -2.6

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-6.2supporter · 95%
Caffeine
-3.2supporter · 66%
Lactose
+1.9no signal · 43%
Dietary fat load
-1.4no signal · 23%
Alcohol
+1.2no signal · 25%
Histamine load
-0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3.5 · butyrate capacity 70/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 35 ms
Sleep: 7.4 h
Steps: 5,945
Resting HR: 68 bpm

Daily log: GI score 22, nutritional resilience 70, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-03140	42%	S20	AD-05	improved	79
P-03187	39%	S12	AD-05	no change	80
P-03482	30%	S05	AD-05	no change	67
P-03105	27%	S12	AD-05	no change	60
P-03208	28%	S02	BR-03	improved	57
P-03288	47%	S15	CR-01	improved	88
P-03001	42%	S04	CR-01	improved	87
P-03353	48%	S06	DT-01	no change	83
P-03431	44%	S05	DT-01	improved	88
P-03449	31%	S14	DT-01	improved	79
P-03473	28%	S07	DT-01	improved	70
P-03172	25%	S17	DT-01	no change	48